These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J; Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993 [TBL] [Abstract][Full Text] [Related]
9. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
10. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Marín R; Gorostidi M; Fernández-Vega F; Alvarez-Navascués R Kidney Int Suppl; 2005 Dec; (99):S52-6. PubMed ID: 16336577 [TBL] [Abstract][Full Text] [Related]
11. The link between hypertension and nephrosclerosis. Freedman BI; Iskandar SS; Appel RG Am J Kidney Dis; 1995 Feb; 25(2):207-21. PubMed ID: 7847347 [TBL] [Abstract][Full Text] [Related]
12. Recommendations for the management of special populations: renal disease in diabetes. Raij L Am J Hypertens; 2003 Nov; 16(11 Pt 2):46S-49S. PubMed ID: 14625161 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive drugs and the kidney. Nadim MK; Dua R; Campese VM Curr Cardiol Rep; 2004 Nov; 6(6):403-8. PubMed ID: 15485598 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Fogo A; Breyer JA; Smith MC; Cleveland WH; Agodoa L; Kirk KA; Glassock R Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739 [TBL] [Abstract][Full Text] [Related]
15. Treatment of diabetic nephropathy with angiotensin II receptor antagonist. Lewis EJ; Lewis JB Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737 [TBL] [Abstract][Full Text] [Related]
16. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease. Weir MR Am J Hypertens; 2005 Apr; 18(4 Pt 2):100S-105S. PubMed ID: 15837552 [TBL] [Abstract][Full Text] [Related]
17. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S; JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927 [TBL] [Abstract][Full Text] [Related]
18. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria. Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229 [TBL] [Abstract][Full Text] [Related]
19. Drug treatment for hypertensive patients in special situations: diabetes and hypertension. Mogensen CE Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of hypertensive renal damage: implications for therapy. Bidani AK; Griffin KA Hypertension; 2004 Nov; 44(5):595-601. PubMed ID: 15452024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]